<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Anthralin: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Anthralin: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Anthralin: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="11165" href="/d/html/11165.html" rel="external">see "Anthralin: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="117809" href="/d/html/117809.html" rel="external">see "Anthralin: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F135607"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Dritho-Creme HP [DSC];</li>
<li>Zithranol</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F135639"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Antipsoriatic Agent;</li>
<li>
                        Keratolytic Agent</li></ul></div>
<div class="block doa drugH1Div" id="F135611"><span class="drugH1">Dosing: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Note: </b>Dritho-Creme HP has been discontinued in the United States for &gt;1 year.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="9c51dc6e-ca0a-48cc-bfad-6cb5d9403c14">Psoriasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:0em;display:inline">
<b>Psoriasis:</b> Topical:</p>
<p style="text-indent:-2em;margin-left:2em;">Cream: Generally, apply once daily or as directed. The irritant potential of anthralin is directly related to the strength being used and each patient's individual tolerance. Always commence treatment using a short, daily contact time (5 to 10 minutes) for at least 1 week using the lowest strength possible. Contact time may be gradually increased (to 30 minutes) as tolerated.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Skin application:</i> Apply sparingly only to psoriatic lesions and rub gently and carefully into the skin until absorbed. Avoid applying an excessive quantity which may cause unnecessary soiling and staining of the clothing or bed linen.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Scalp application:</i> Comb hair to remove scalar debris, wet hair and, after suitably parting, rub cream well into the lesions, taking care to prevent the cream from spreading onto the forehead.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Remove by washing or showering; optimal period of contact will vary according to the strength used and the patient's response to treatment. Continue treatment until the skin is entirely clear (ie, when there is nothing to feel with the fingers and the texture is normal).</p>
<p style="text-indent:-2em;margin-left:2em;">Shampoo: Rub shampoo onto wet scalp, lather and leave on scalp for 3 to 5 minutes; rinse thoroughly; apply 3 to 4 times weekly</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990034"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;margin-left:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doha drugH1Div" id="F50987350"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;margin-left:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doe drugH1Div" id="F135612"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F27778656"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="117809" href="/d/html/117809.html" rel="external">see "Anthralin: Pediatric drug information"</a>)</p>
<p style="text-indent:0em;display:inline">
<b>Note: </b>Dritho-Creme HP has been discontinued in the United States for &gt;1 year.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="d7c83a95-5615-4742-bc5b-d4be859f010b">Scalp psoriasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Scalp psoriasis: </b>Children ≥12 years and Adolescents: Topical: Shampoo: Rub shampoo onto wet scalp, lather and leave on scalp for 3 to 5 minutes; rinse thoroughly; apply 3 to 4 times weekly.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51064864"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block dohp drugH1Div" id="F51064865"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block adr drugH1Div" id="F135590"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Frequency not defined.</p>
<p style="text-indent:-2em;margin-left:2em;">Dermatologic: Allergic contact sensitivity, erythema, hair discoloration (temporary), nail discoloration (temporary), skin discoloration (temporary)</p>
<p style="text-indent:-2em;margin-left:2em;">Miscellaneous: Transient irritation (uninvolved skin)</p></div>
<div class="block coi drugH1Div" id="F135600"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to anthralin or any component of the formulation; acute psoriasis (acutely or actively inflamed psoriatic eruptions)</p></div>
<div class="block war drugH1Div" id="F135587"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Redness: If redness is observed, reduce frequency of dosage or discontinue application.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Staining: May stain skin, hair, fingernails (temporary), or fabrics (may be permanent).</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Appropriate application: Avoid eye contact; should generally not be applied to opposing skin surfaces that may rub or touch (eg, skin folds of the groin, axilla, and breasts) and high strengths should not be used on these sites; do not apply to genitalia.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Prolonged/extensive use: Use with caution in patients extensive and prolonged applications. </p></div>
<div class="block prod-avail drugH1Div" id="F58246289"><span class="drugH1">Product Availability</span>
<p style="text-indent:0em;display:inline">Dritho-Creme HP has been discontinued in the United States for &gt;1 year.</p></div>
<div class="block foc drugH1Div" id="F135596"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Dritho-Creme HP: 1% (50 g [DSC]) [contains methylparaben]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Shampoo, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Zithranol: 1% (85 g) [contains fd&amp;c blue #1 (brilliant blue)]</p></div>
<div class="block geq drugH1Div" id="F135583"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block fee drugH1Div" id="F135602"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Shampoo</b> (Zithranol External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $13.55</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F135598"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">May apply using latex gloves to prevent staining of fingers. Apply directly to plaques; rub in gently but thoroughly; avoid application to unaffected skin. When applying to scalp, part hair in one-inch segments to reach plaques. Remove by washing after conclusion of prescribed contact period. When rinsing, take care to avoid contact with eyes. Immediately clean tub or shower to prevent staining. Dry off using old towel (stains on fabric may be permanent). Petroleum jelly may be used around the edges of plaques, in body folds, or skin creases to prevent irritation of unaffected skin.</p></div>
<div class="block admp drugH1Div" id="F52612243"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Topical: May apply using latex gloves to prevent staining of fingers</p>
<p style="text-indent:-2em;margin-left:2em;">Cream: Adults: Apply directly to plaques; rub in gently but thoroughly; avoid application to unaffected skin. Petroleum jelly may be used around the edges of plaques, in body folds, or skin creases to prevent irritation of unaffected skin.</p>
<p style="text-indent:-2em;margin-left:2em;">Shampoo: When applying to scalp, part hair in 1-inch segments to reach plaques. Remove by washing after conclusion of prescribed contact period. When rinsing, take care to avoid contact with eyes. Immediately clean tub or shower to prevent staining. Dry off using old towel (stains on fabric may be permanent).</p></div>
<div class="block use drugH1Div" id="F135597"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Plaque psoriasis:</b> Treatment of chronic plaque psoriasis</p></div>
<div class="block cyt drugH1Div" id="F13298755"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F135591"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Aminolevulinic Acid (Systemic): Photosensitizing Agents may enhance the photosensitizing effect of Aminolevulinic Acid (Systemic). <i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Aminolevulinic Acid (Topical): Photosensitizing Agents may enhance the photosensitizing effect of Aminolevulinic Acid (Topical). <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Methoxsalen (Systemic): Photosensitizing Agents may enhance the photosensitizing effect of Methoxsalen (Systemic). <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Verteporfin: Photosensitizing Agents may enhance the photosensitizing effect of Verteporfin. <i> Risk C: Monitor therapy</i></p></div>
<div class="block pri drugH1Div" id="F13332961"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Animal reproduction studies have not been conducted.</p></div>
<div class="block brc drugH1Div" id="F20547219"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">It is not known if anthralin is excreted in breast milk. Due to the potential for serious adverse reactions in the nursing infant, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of treatment to the mother.</p></div>
<div class="block pha drugH1Div" id="F135586"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Reduction of the mitotic rate and proliferation of epidermal cells in psoriasis by inhibiting synthesis of nucleic protein from inhibition of DNA synthesis to affected areas</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F135603"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Micanol</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Dithrocream | Micanol</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Micanol</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Micanol</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Dithrocream | Micanol</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Anthra west | Psoranol</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Micanol</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Psoradrate</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Dithrocream | Exolan | Micanol</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Dithrocream | Micanol</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Dithrocream | Micanol</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Anthrin</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Dithrocream</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Aft micanol</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Anthralin | Micanol | Psoriatec | Zithranol</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Micanol | Psoradrate</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Micanol</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-Drithro-Creme.1">
<a name="Drithro-Creme.1"></a>Drithro-Creme HP (anthralin) [prescribing information]. Collegeville, PA: Summers Laboratories Inc; October 2014.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8785886">
<a name="8785886"></a>Silverman A, Menter A, and Hairston JL, “Tars and Anthralins,” <i>Dermatol Clin</i>, 1995, 13(4):817-33.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/anthralin-drug-information/abstract-text/8785886/pubmed" id="8785886" target="_blank">8785886</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ZithranolRR.1">
<a name="ZithranolRR.1"></a>Zithranol-RR cream (anthralin) [prescribing information]. Vernon Hills, IL: Elorac, Inc; January 2010.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Zithranol.1">
<a name="Zithranol.1"></a>Zithranol shampoo (anthralin) [prescribing information]. Vernon Hills, IL: Elorac, Inc; October 2011.</div>
</li></ol></div><div id="topicVersionRevision">Topic 8814 Version 128.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
